Net Medical Xpress Announces Company's Specialists to Present at Rural Telemedicine Conference
ALBUQUERQUE, N.M., Sept. 4, 2012 /PRNewswire/ -- New Mexico Software, Inc., d/b/a Net Medical Xpress (OTC Bulletin Board NMXC), announced today that John Tanner, MD, the company's chief medical officer (CMO), and David McCraney, MD, the company's chief neurologist, will present at a rural telemedicine conference in September.
The Role of Tele-health in the Management of Rural Neuro-Emergencies Conference is scheduled for September 14, 2012 in Albuquerque, NM. Online registration is available. The website is located at: http://som.unm.edu/cme/2012/Neuroemergencies.html
Rapid advances in telehealth technology are driving major improvements in standards of care that in turn are bridging the quality gap between rural and urban care. As a result telehealth is enabling timely, high quality and safe patient care in neuro-emergencies. Collaboration of resources among facilities also reduces health disparities and costs and improves quality of life for the families.
Net Medical Xpress offers clinical and diagnostic programs using advanced telemedicine solutions for rural hospitals. The company also develops FDA 510k cleared all-inclusive PACS and Safety Pilot platforms for the medical market.
Net Medical Xpress' Specialist Program provides medical specialists to rural medical facilities on an as needed basis eliminating the need for and cost of full time staffing in infrequently needed specialties. The web-based program enables specialists located in population centers with the ability to make real-time assessments of patients at rural medical facilities through a secure and HIPAA compliant video examination, eliminating unnecessary transport that places additional financial burden and emotional strain on patients.
About Net Medical Xpress, a trade name of New Mexico Software, Inc:
Net Medical Express is a medical services company that provides clinical and diagnostic programs using advanced telemedicine solutions for rural hospitals. The company also develops FDA 510k-cleared and all-inclusive PACS products within the preventative, comprehensive, and critical healthcare segments. For more information, visit www.netmedical.com or www.nmxs.com or contact Dick Govatski, president and CEO, at 505-255-1999 or firstname.lastname@example.org.
An investment profile on New Mexico Software may be found at http://www.hawkassociates.com/profile/nmxc.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.
For more investor-related questions contact Frank Hawkins, Hawk Associates, at 305-451-1888 or Dick Govatski at 505-255-1999 (email@example.com).
This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company's Forms 10-K and 10-Q filed with the SEC.
SOURCE New Mexico Software, Inc.
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.